Literature DB >> 30429966

Porphyrins as ligands for 64copper: background and trends.

Edgar Aguilar-Ortíz1, Amir R Jalilian2, Miguel A Ávila-Rodríguez1.   

Abstract

Porphyrins and 64Cu have emerged as a novel synergic option for applications in PET molecular imaging. Both the characteristics and photophysical properties of macrocyclic porphyrins and the relatively long half-life of the copper isotope, in addition to the increased tumor-specific uptake of porphyrins compared to normal cells, make this complex an attractive option not only for diagnosis but also for therapeutic applications. Herein, we present an overview of the latest results on the development of PET agents based on porphyrins and 64Cu, including methods used to improve the selectivity of these macrocycles when conjugated with biological units such as monoclonal antibodies, peptides or proteins.

Entities:  

Year:  2018        PMID: 30429966      PMCID: PMC6194497          DOI: 10.1039/c8md00263k

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  83 in total

Review 1.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 2.  Advances in copper complexes as anticancer agents.

Authors:  Carlo Santini; Maura Pellei; Valentina Gandin; Marina Porchia; Francesco Tisato; Cristina Marzano
Journal:  Chem Rev       Date:  2013-10-08       Impact factor: 60.622

3.  Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.

Authors:  Sibaprasad Bhattacharyya; Manish Dixit
Journal:  Dalton Trans       Date:  2011-05-03       Impact factor: 4.390

Review 4.  Photosensitiser-antibody conjugates for photodynamic therapy.

Authors:  Aaron J Bullous; Cristina M A Alonso; Ross W Boyle
Journal:  Photochem Photobiol Sci       Date:  2011-03-15       Impact factor: 3.982

5.  ATP-dependent incorporation of 20S protease into the 26S complex that degrades proteins conjugated to ubiquitin.

Authors:  E Eytan; D Ganoth; T Armon; A Hershko
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 6.  Tumour targeting with radiometals for diagnosis and therapy.

Authors:  Caterina F Ramogida; Chris Orvig
Journal:  Chem Commun (Camb)       Date:  2013-05-25       Impact factor: 6.222

Review 7.  Photosensitizers: therapy and detection of malignant tumors.

Authors:  T J Dougherty
Journal:  Photochem Photobiol       Date:  1987-06       Impact factor: 3.421

8.  Cas IIgly induces apoptosis in glioma C6 cells in vitro and in vivo through caspase-dependent and caspase-independent mechanisms.

Authors:  Cristina Trejo-Solís; Guadalupe Palencia; Sergio Zúñiga; Andrea Rodríguez-Ropon; Laura Osorio-Rico; Sanchez Torres Luvia; Isabel Gracia-Mora; Lucrecia Marquez-Rosado; Aurora Sánchez; Miguel E Moreno-García; Arturo Cruz; María Elena Bravo-Gómez; Lena Ruiz-Ramírez; Sara Rodríguez-Enriquez; Julio Sotelo
Journal:  Neoplasia       Date:  2005-06       Impact factor: 5.715

9.  A simple and efficient method of nickel electrodeposition for the cyclotron production of (64)Cu.

Authors:  Juan C Manrique-Arias; Miguel A Avila-Rodriguez
Journal:  Appl Radiat Isot       Date:  2014-02-12       Impact factor: 1.513

10.  Biodistribution and radiation dosimetry of [64Cu]copper dichloride: first-in-human study in healthy volunteers.

Authors:  M A Avila-Rodriguez; C Rios; J Carrasco-Hernandez; J C Manrique-Arias; R Martinez-Hernandez; F O García-Pérez; A R Jalilian; E Martinez-Rodriguez; M E Romero-Piña; A Diaz-Ruiz
Journal:  EJNMMI Res       Date:  2017-12-12       Impact factor: 3.138

View more
  2 in total

Review 1.  Porphyrins as Chelating Agents for Molecular Imaging in Nuclear Medicine.

Authors:  Krystyna Pyrzynska; Krzysztof Kilian; Mateusz Pęgier
Journal:  Molecules       Date:  2022-05-21       Impact factor: 4.927

Review 2.  Recent Advances in Photosensitizers as Multifunctional Theranostic Agents for Imaging-Guided Photodynamic Therapy of Cancer.

Authors:  Paromita Sarbadhikary; Blassan P George; Heidi Abrahamse
Journal:  Theranostics       Date:  2021-08-26       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.